$RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. Stock $rajaf

$rajaf Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023039368 Filed on May 15, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$53.30K	$448.8K
YoY Change		-48.96%
Cost Of Revenue	$13.75K	$515.5K
YoY Change		-51.17%
Gross Profit	$39.55K	-$66.67K
YoY Change		-62.16%
Gross Profit Margin	74.2%	-14.86%
Selling, General & Admin	$336.2K	$576.0K
YoY Change		91.39%
% of Gross Profit	850.16%
Research & Development	$118.4K	$118.4K
YoY Change		372.79%
% of Gross Profit	299.47%
Depreciation & Amortization	$168.9K	$24.76K
YoY Change		5795.24%
% of Gross Profit	427.05%
Operating Expenses	$454.7K	$576.0K
YoY Change		91.39%
Operating Profit	-$415.1K	-$642.7K
YoY Change		34.69%
Interest Expense	$10.00	$71.77K
YoY Change		481.15%
% of Operating Profit
Other Income/Expense, Net		-$76.60K
YoY Change		468.45%
Pretax Income	-$415.1K	-$415.1K
YoY Change		247.72%
Income Tax	$0.00	$792.00
% Of Pretax Income
Net Earnings	-$720.1K	-$720.1K
YoY Change		46.66%
Net Earnings / Revenue	-1351.01%	-160.45%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	111.1M shares	104.4M shares
Diluted Shares Outstanding		104.4M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.630K	$6.630K
YoY Change		-93.35%
Cash & Equivalents	$16.10K	$6.630K	$99.68K
Short-Term Investments
Other Short-Term Assets	$485.4K	$485.4K
YoY Change		1670.96%
Inventory	$313.5K		$480.4K
Prepaid Expenses
Receivables	$149.5K		$358.0K
Other Receivables	$9.502K
Total Short-Term Assets	$501.6K	$501.6K	$1.131M
YoY Change	-55.65%	-55.15%	19.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.425M	$253.7K	$1.714M
YoY Change	-16.85%	-87.23%	0.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.350M	$1.350M
YoY Change		824.15%
Total Long-Term Assets	$1.603M	$1.603M	$2.132M
YoY Change	-24.81%	-24.81%	13.61%
TOTAL ASSETS
Total Short-Term Assets	$501.6K	$501.6K	$1.131M
Total Long-Term Assets	$1.603M	$1.603M	$2.132M
Total Assets	$2.105M	$2.105M	$3.263M
YoY Change	-35.49%	-35.25%	15.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$751.1K	$0.00	$111.7K
YoY Change	572.48%	-100.0%	90709.76%
Accrued Expenses	$62.75K	$57.11K	$56.41K
YoY Change	11.25%	-53.28%	91.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$57.11K
YoY Change
Total Short-Term Liabilities	$2.935M	$2.521M	$2.922M
YoY Change	0.47%	-13.33%	21.05%
LONG-TERM LIABILITIES
Long-Term Debt	$414.0K	$414.0K
YoY Change		0.0%
Other Long-Term Liabilities	$121.1K	$121.1K
YoY Change		-40.46%
Total Long-Term Liabilities	$414.0K	$535.1K
YoY Change		-13.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.935M	$2.521M	$2.922M
Total Long-Term Liabilities	$414.0K	$535.1K
Total Liabilities	$3.056M	$3.056M	$3.539M
YoY Change	-13.64%	-13.33%	24.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.225M		-$504.5K
YoY Change	142.74%		3643.56%
Common Stock	$11.11K		$10.00K
YoY Change	11.12%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$951.3K	-$951.3K	-$275.8K
YoY Change
Total Liabilities & Shareholders Equity	$2.105M	$2.105M	$3.263M
YoY Change	-35.49%	-35.25%	15.48%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$720.1K	-$720.1K
YoY Change		46.66%
Depreciation, Depletion And Amortization	$168.9K	$24.76K
YoY Change		5795.24%
Cash From Operating Activities	-$321.4K	-$321.4K
YoY Change		-12.04%
INVESTING ACTIVITIES
Capital Expenditures	$480.00	$475.00
YoY Change		-99.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$480.00	-$475.00
YoY Change		-99.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	245.8K	$245.8K
YoY Change		-57.22%
NET CHANGE
Cash From Operating Activities	-321.4K	-$321.4K
Cash From Investing Activities	-480.0	-$475.00
Cash From Financing Activities	245.8K	$245.8K
Net Change In Cash	-76.07K	-$83.58K
YoY Change		-184.1%
FREE CASH FLOW
Cash From Operating Activities	-$321.4K	-$321.4K
Capital Expenditures	$480.00	$475.00
Free Cash Flow	-$321.9K	-$321.9K
YoY Change		-32.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-269315
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ruiguang Road, Neihu District,
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Taipei City
CY2022	dei	Entity Address Country EntityAddressCountry	TW
CY2022	dei	Security12b Title Security12bTitle	None
CY2022	dei	Trading Symbol TradingSymbol	None
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	111120000	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Name AuditorName	Keith K Zhen CPA
CY2022	dei	Auditor Firm AuditorFirmId	6673
CY2022	dei	Auditor Location AuditorLocation	Brooklyn, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16100	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99684	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	294	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	149510	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	358006	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	12880	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	16476	usd
CY2020Q4	us-gaap	Other Receivables OtherReceivables	2764	usd
CY2022Q4	us-gaap	Supplies Supplies	9532	usd
CY2021Q4	us-gaap	Supplies Supplies	27410	usd
CY2020Q4	us-gaap	Supplies Supplies	19457	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	313530	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	480352	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	685410	usd
CY2021Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	148900	usd
CY2020Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	241082	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	501552	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1130828	usd
CY2020Q4	us-gaap	Assets Current AssetsCurrent	949007	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	146040	usd
CY2020Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	146040	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1425135	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1713954	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1712162	usd
CY2022Q4	us-gaap	Operating Lease Residual Value Of Leased Asset OperatingLeaseResidualValueOfLeasedAsset	178166	usd
CY2021Q4	us-gaap	Operating Lease Residual Value Of Leased Asset OperatingLeaseResidualValueOfLeasedAsset	272216	usd
CY2020Q4	us-gaap	Operating Lease Residual Value Of Leased Asset OperatingLeaseResidualValueOfLeasedAsset	18502	usd
CY2022Q4	us-gaap	Assets Assets	2104853	usd
CY2021Q4	us-gaap	Assets Assets	3263038	usd
CY2020Q4	us-gaap	Assets Assets	2825711	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	751135	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	111696	usd
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	123	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	263628	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1115902	usd
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1093557	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	62754	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	56407	usd
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29529	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1386504	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1571284	usd
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1285559	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	57109	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66237	usd
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4699	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	414000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2935130	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2921526	usd
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2413467	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	414000	usd
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	414000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	121057	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	203325	usd
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11056	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3056187	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3538851	usd
CY2020Q4	us-gaap	Liabilities Liabilities	2838523	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111120000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111120000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111120000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111120000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111120000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111120000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11112	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	cik1885680	Common Stock Tobe Issued CommonStockTobeIssued	222400	usd
CY2020Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	10000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	221288	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1224575	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-504482	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13476	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	40841	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3731	usd
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	664	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-951334	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-275813	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-12812	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2104853	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3263038	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2825711	usd
CY2022	us-gaap	Revenues Revenues	448785	usd
CY2021	us-gaap	Revenues Revenues	879318	usd
	us-gaap	Revenues Revenues	134720	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	515457	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1055530	usd
	us-gaap	Cost Of Revenue CostOfRevenue	40648	usd
CY2022	us-gaap	Gross Profit GrossProfit	-66672	usd
CY2021	us-gaap	Gross Profit GrossProfit	-176212	usd
	us-gaap	Gross Profit GrossProfit	94072	usd
CY2022	cik1885680	Advertising And Promotion Fees AdvertisingAndPromotionFees	3123	usd
CY2021	cik1885680	Advertising And Promotion Fees AdvertisingAndPromotionFees	22735	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	318	usd
CY2021	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	4563	usd
	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	7337	usd
CY2022	us-gaap	Selling Expense SellingExpense	3441	usd
CY2021	us-gaap	Selling Expense SellingExpense	27298	usd
	us-gaap	Selling Expense SellingExpense	7337	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	110938	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	80225	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	42118	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	184434	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	109212	usd
	us-gaap	Professional Fees ProfessionalFees	25000	usd
CY2022	us-gaap	Exchange Fees ExchangeFees	9499	usd
CY2021	us-gaap	Exchange Fees ExchangeFees	7724	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	3588	usd
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	4110	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	1721	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118444	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25052	usd
CY2022	us-gaap	Depreciation Depreciation	24760	usd
CY2021	us-gaap	Depreciation Depreciation	420	usd
	us-gaap	Depreciation Depreciation	112	usd
CY2022	us-gaap	Other Expenses OtherExpenses	35690	usd
CY2021	us-gaap	Other Expenses OtherExpenses	16971	usd
	us-gaap	Other Expenses OtherExpenses	3185	usd
CY2022	cik1885680	Rental Expenses RentalExpenses	68818	usd
CY2021	cik1885680	Rental Expenses RentalExpenses	6542	usd
	cik1885680	Rental Expenses RentalExpenses	348	usd
CY2022	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	3068	usd
CY2021	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	13613	usd
	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	3769	usd
CY2022	us-gaap	Entertainment License Agreement For Program Material Amortization Expense EntertainmentLicenseAgreementForProgramMaterialAmortizationExpense	13350	usd
CY2021	us-gaap	Entertainment License Agreement For Program Material Amortization Expense EntertainmentLicenseAgreementForProgramMaterialAmortizationExpense	9801	usd
	us-gaap	Entertainment License Agreement For Program Material Amortization Expense EntertainmentLicenseAgreementForProgramMaterialAmortizationExpense	1750	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	572589	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	273670	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	78003	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	576030	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	300968	usd
	us-gaap	Operating Expenses OperatingExpenses	85340	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-642702	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-477180	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	8732	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	28	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	13	usd
	us-gaap	Interest Income Other InterestIncomeOther	7	usd
CY2022	us-gaap	Interest Expense InterestExpense	71772	usd
CY2021	us-gaap	Interest Expense InterestExpense	12350	usd
	us-gaap	Interest Expense InterestExpense	20284	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4855	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1138	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-76599	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13475	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20266	usd
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-719301	usd
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-490655	usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-11534	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	792	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	351	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1942	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-720093	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-491006	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13476	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	44572	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4395	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	664	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-675521	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-495401	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12812	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104417534	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-13476	usd
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	664	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-12812	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	222400	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-491006	usd
CY2021	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-4395	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-275813	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-720093	usd
CY2022	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	44572	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-951334	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-720093	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-491006	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13476	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168899	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149238	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26635	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	58986	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	9846	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1873	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	84709	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	385828	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1177	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-185797	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	353665	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	-2172	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	13533	usd
	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	2614	usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-16161	usd
CY2021	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	7386	usd
	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	18401	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-48833	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	166681	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	648216	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-122450	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	105846	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	500194	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10903	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	25838	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27927	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-56472	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-9688	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4471	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-321378	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-365363	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-130549	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	475	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	110815	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1111749	usd
	cik1885680	Advances And Loans Made To Related Parties AdvancesAndLoansMadeToRelatedParties	-388960	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-475	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-110815	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1500709	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	232400	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	414000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	397210	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	582806	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1235228	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-151423	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-240702	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-17691	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	245787	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	574504	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1631537	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7518	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1064	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-83584	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	99390	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	294	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99684	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16100	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99684	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	792	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	351	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1942	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	261351	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	19371	usd
CY2022	cik1885680	Termination Of Rou Assets And Lease Liabilities TerminationOfROUAssetsAndLeaseLiabilities	19873	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	534138	usd
CY2022Q4	us-gaap-sup	Cash Held In Foreign Currency CashHeldInForeignCurrency	1	hkd
CY2022Q4	us-gaap-sup	Cash Held In Foreign Currency CashHeldInForeignCurrency	1	cny
CY2022Q4	us-gaap-sup	Cash Held In Foreign Currency CashHeldInForeignCurrency	1	twd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Use of Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as operating environment changes. Significant estimates and assumptions by management include, among others, estimated life and impairment of long-lived assets, allowance for doubtful accounts, contingencies, valuation of inventories and income taxes including the valuation allowance for deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">While the Company believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p>
CY2022Q4	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1177	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	118444	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	25052	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in">Concentration of Credit Risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Financial instruments the Company holds that are subject to concentrations of credit risk are cash, restricted cash, notes receivables and accounts receivable arising from its normal business activities. The Company places its cash and restricted cash in what it believes to be credit-worthy financial institutions. The Company routinely assesses the credit status of its customers and, based upon factors surrounding the credit risks, establishes an allowance, if required, for uncollectible accounts. The company believes its accounts receivable and others receivable credit risk exposure beyond such allowance is limited.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"> </p>
CY2022	cik1885680	Related Party Generally Defined Percentage RelatedPartyGenerallyDefinedPercentage	0.10	pure
CY2022	cik1885680	Net Incomes Loss NetIncomesLoss	-720093	usd
CY2021	cik1885680	Net Incomes Loss NetIncomesLoss	-491006	usd
	cik1885680	Net Incomes Loss NetIncomesLoss	13476	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1224575	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	149510	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	224097	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	133909	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	149510	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	358006	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	207645	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	466449	usd
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	20328	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	266488	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	390588	usd
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	665082	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	12823	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	13878	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	173426	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	390563	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	313530	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	480352	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	685410	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	84709	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	385828	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	635040	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	687318	usd
CY2020Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	670894	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1017206	usd
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1102141	usd
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1065513	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	103201	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	104417	usd
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3918	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1755447	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1893876	usd
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1740325	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	330312	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	179922	usd
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28163	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1425135	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1713954	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1712162	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	168899	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	149238	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	26635	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	144139	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	148818	usd
	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	26523	usd
CY2022	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	24760	usd
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	420	usd
	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	112	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	133909	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	146040	usd
CY2020Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Outstanding Balance CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesOutstandingBalance	146040	usd
	cik1885680	Construction Areas ConstructionAreas	1788	sqm
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	263628	usd
CY2021Q3	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	100000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	148900000000	usd
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	241082000000	usd
	us-gaap-sup	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	17691	usd
	cik1885680	Accured Interest AccuredInterest	20284	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1386504	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1571284	usd
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1285559	usd
CY2022	us-gaap	Sale Leaseback Transaction Lease Terms SaleLeasebackTransactionLeaseTerms	These leases have remaining lease terms of 6 months to 4 years.
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	67755	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	74887	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2176	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M4D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M29D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0394	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0398	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	62999	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	62999	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	62999	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	188997	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	10831	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	178166	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	57109	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	121057	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	62712	usd
CY2021Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	54203	usd
CY2020Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	26500	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	42	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1785	usd
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	771	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	419	usd
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2258	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	62754	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	56407	usd
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	29529	usd
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance Covered LoansAndLeasesReceivableAllowanceCovered	414000	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	414000	usd
CY2021	us-gaap	Payments For Loans PaymentsForLoans	414000	usd
CY2020	us-gaap	Payments For Loans PaymentsForLoans	414000	usd
CY2020Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1	shares
CY2020Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	100000000	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	10000	usd
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	11120000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2021Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	222400	usd
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	111120000	shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	111120000	shares
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0825	pure
CY2022Q4	us-gaap	Income Tax Examination Increase Decrease In Liability From Prior Year IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear	2000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2022Q4	us-gaap	Retail Land Sales Receivables Stated Interest Rate RetailLandSalesReceivablesStatedInterestRate	0.05	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment	0.20	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.25	pure
CY2022	cik1885680	Current Income Tax Expense Benefit1 CurrentIncomeTaxExpenseBenefit1	792	usd
CY2021	cik1885680	Current Income Tax Expense Benefit1 CurrentIncomeTaxExpenseBenefit1	351	usd
CY2020	cik1885680	Current Income Tax Expense Benefit1 CurrentIncomeTaxExpenseBenefit1	1942	usd
CY2022	cik1885680	Deferred Income Tax Assets Net1 DeferredIncomeTaxAssetsNet1	792	usd
CY2021	cik1885680	Deferred Income Tax Assets Net1 DeferredIncomeTaxAssetsNet1	351	usd
CY2020	cik1885680	Deferred Income Tax Assets Net1 DeferredIncomeTaxAssetsNet1	1942	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	cik1885680	Common Stock Tobe Issued CommonStockTobeIssued		usd
CY2020Q4	cik1885680	Common Stock Tobe Issued CommonStockTobeIssued		usd
CY2022	us-gaap	Accounts Receivable Sale AccountsReceivableSale	411131	usd
CY2022	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.916	pure
CY2021	us-gaap	Accounts Receivable Sale AccountsReceivableSale	768507	usd
CY2021	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.874	pure
CY2020	us-gaap	Accounts Receivable Sale AccountsReceivableSale	134720	usd
CY2020	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	1	pure
CY2022	us-gaap	Payments To Suppliers PaymentsToSuppliers	23784	usd
CY2022	cik1885680	Purchase Percentage PurchasePercentage	0.832	pure
CY2021	us-gaap	Payments To Suppliers PaymentsToSuppliers	218521	usd
CY2021	cik1885680	Purchase Percentage PurchasePercentage	0.797	pure
	us-gaap	Payments To Suppliers PaymentsToSuppliers	577945	usd
	cik1885680	Purchase Percentage PurchasePercentage	0.99	pure
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000	cny
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	71821	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	3000000	twd
CY2022	dei	Entity Registrant Name EntityRegistrantName	Cordyceps Sunshine Biotech Holdings Co., Ltd.
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	6th Fl., No. 15, Lane 548,
CY2022	dei	Security Exchange Name SecurityExchangeName	NONE
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent		usd
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties		usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2021Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	cik1885680	Advertising And Promotion Fees AdvertisingAndPromotionFees		usd
	us-gaap	Exchange Fees ExchangeFees		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	100000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	100000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104417534	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	cik1885680	Advances And Loans Made To Related Parties AdvancesAndLoansMadeToRelatedParties		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	cik1885680	Termination Of Rou Assets And Lease Liabilities TerminationOfROUAssetsAndLeaseLiabilities		usd
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent		usd
CY2020Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies		usd
CY2020Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount		usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022	cik1885680	Deferred Income Tax Expense Benefit1 DeferredIncomeTaxExpenseBenefit1		usd
CY2021	cik1885680	Deferred Income Tax Expense Benefit1 DeferredIncomeTaxExpenseBenefit1		usd
CY2020	cik1885680	Deferred Income Tax Expense Benefit1 DeferredIncomeTaxExpenseBenefit1		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001885680

Files In Submission

Name	View Source	Status
cik1885680-20221231_cal.xml	Edgar Link	unprocessable
0001213900-23-039368-index-headers.html	Edgar Link	pending
0001213900-23-039368-index.html	Edgar Link	pending
0001213900-23-039368.txt	Edgar Link	pending
0001213900-23-039368-xbrl.zip	Edgar Link	pending
cik1885680-20221231.xsd	Edgar Link	pending
f20f2022ex11-2_cordycepssun.htm	Edgar Link	pending
f20f2022ex12-1_cordycepssun.htm	Edgar Link	pending
f20f2022ex12-2_cordycepssun.htm	Edgar Link	pending
f20f2022ex13-1_cordycepssun.htm	Edgar Link	pending
f20f2022ex13-2_cordycepssun.htm	Edgar Link	pending
f20f2022_cordycep.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
cik1885680-20221231_def.xml	Edgar Link	unprocessable
cik1885680-20221231_pre.xml	Edgar Link	unprocessable
cik1885680-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f20f2022_cordycep_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. Stock $rajaf

2022 Q4 Form 20-F Financial Statement

#000121390023039368 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RAJAF Cordyceps Sunshine Biotech Holdings Co., Ltd. Stock $rajaf

2022 Q4 Form 20-F Financial Statement

#000121390023039368 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. Stock $rajaf